TTO Swabs Versus Baby Shampoo in Patients With Seborrehic Blepharitis
- Conditions
- Seborrheic Blepharitis
- Interventions
- Drug: Swabs containing tea tree oil and chamomile oilDrug: Baby shampoo
- Registration Number
- NCT04678531
- Lead Sponsor
- Istanbul University - Cerrahpasa (IUC)
- Brief Summary
The aim of the study was to compare the efficacy of lid swabs containing tea tree oil (TTO) and chamomile oil and baby shampoo (BS) in the treatment of seborrheic blepharitis.
- Detailed Description
After being informed about the study and potential risks, all patients giving written consent will have a complete ophthalmological examination to determine eligibilty for study entry. At week 0, patients who meet the eligibility requirements will be randomized in a double blind manner (participant and investigator) in a 1:1 ratio using block randomization to lid wipes containing tea tree oil (TTO) and chamomile oil or baby shampoo (twice daily).
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 49
- Diagnosis of seborrheic blepharitis
- Patients with ophthalmological pathologies that may affect the tear film functions including ocular rosacea, contact lens use, history of any ocular surgery, or patients with systemic pathologies or those using systemic medications that may affect the tear film functions
- Patients younger than 18-year-old
- Patients who used any treatment for blepharitis within the 6 months prior to the examination
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Swabs containing tea tree oil and chamomile oil Swabs containing tea tree oil and chamomile oil The swabs will be applied on the eyelids twice a day for 8 weeks followed by a discontinuation period of 4 weeks. Baby shampoo Baby shampoo Baby shampoo will be applied on the eyelids twice a day for 8 weeks followed by a discontinuation period of 4 weeks
- Primary Outcome Measures
Name Time Method Efficacy of the treatment assessed by the change in Blepharitis Symptom measure (BLISS) score Change from Baseline at 12 weeks BLISS score is calculated according to the answers given to the questionnaire. Higher BLISS scores is related to a worse outcome. (Range is between 0 and 39)
- Secondary Outcome Measures
Name Time Method Efficacy of the treatment assessed by the change in the Schirmer's test results 0-4-8-12 weeks Dry eye evaluation will be made with Schirmer's test.
Efficacy of the treatment assessed by the change in the tear breakup time 0-4-8-12 weeks Dry eye evaluation will be made with tear breakup time.
Efficacy of the treatment assessed by the change in Demodex mite count by light microscopy 0-4-8-12 weeks The number of mites in the epilated 4 eyelashes will be counted under microscope.
Efficacy of the treatment assessed by the change in the ocular surface disease index score 0-4-8-12 weeks OSDI scores are calculated according to the responses to the questionnaire. Higher values are related to a worse outcome (range is between 0-100).
Efficacy of the treatment assessed by the change in the meibomian gland loss 0-4-8-12 weeks Meibomian gland loss will be evaluated using anterior segment analysis system.
Efficacy of the treatment assessed by the change in the non-invasive tear breakup time 0-4-8-12 weeks Dry eye evaluation will be made with non-invasive tear breakup time.
Trial Locations
- Locations (1)
Istanbul University-Cerrahpasa
🇹🇷Istanbul, Turkey